Cite
Cholesterol-GalNAc Dual Conjugation Strategy for Reducing Renal Distribution of Antisense Oligonucleotides.
MLA
Wada, Fumito, et al. “Cholesterol-GalNAc Dual Conjugation Strategy for Reducing Renal Distribution of Antisense Oligonucleotides.” Nucleic Acid Therapeutics, vol. 28, no. 1, Feb. 2018, pp. 50–57. EBSCOhost, https://doi.org/10.1089/nat.2017.0698.
APA
Wada, F., Yamamoto, T., Ueda, T., Sawamura, M., Wada, S., Harada-Shiba, M., & Obika, S. (2018). Cholesterol-GalNAc Dual Conjugation Strategy for Reducing Renal Distribution of Antisense Oligonucleotides. Nucleic Acid Therapeutics, 28(1), 50–57. https://doi.org/10.1089/nat.2017.0698
Chicago
Wada, Fumito, Tsuyoshi Yamamoto, Tetsuya Ueda, Motoki Sawamura, Shunsuke Wada, Mariko Harada-Shiba, and Satoshi Obika. 2018. “Cholesterol-GalNAc Dual Conjugation Strategy for Reducing Renal Distribution of Antisense Oligonucleotides.” Nucleic Acid Therapeutics 28 (1): 50–57. doi:10.1089/nat.2017.0698.